Company: BDRX
Filing Date: 2025-01-17
Form Type: F-1
Source: 0001214659-25-000922
Chunk: 99

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-17
Form: F-1
Chunk 99
---
 or anticipation of such sales, could make it more difficult
for us to sell equity or equity-related securities in the future at a time and at a price that we might otherwise wish to effect sales.

We may also issue Ordinary
Shares (and Depositary Shares underlying such Ordinary Shares) or other securities convertible into Ordinary Shares from time to time
for future acquisitions, including acquisitions of licenses. The issuance of the securities underlying these instruments, or perception
that issuance may occur, will have a dilutive impact on other shareholders and could have a material negative effect on the market price
of our Depositary Shares.

If equity research analysts do not publish research or publish inaccurate or unfavorable research about our business, our stock price and trading volume could decline.

The trading market for our
securities will depend in part on the research and reports that equity research analysts publish about us or our business. If no or few equity research analysts cover our Company, the trading price for oursecurities would be negatively impacted. We do not have any control over the analysts or the content and opinions included in their reports. The price of oursecurities could decline if one or more equity research analysts downgrade oursecurities
or issue other unfavorable commentary or research about us. If one or more equity research analysts ceases coverage of us or fails to publish reports on us regularly, demand for oursecurities could decrease, which in turn could cause the trading price or trading volume of oursecurities to decline.

The rights of holders of Depositary Shares are not the same as the rights of holders of Ordinary Shares.

We are a public limited company
incorporated under the laws of England and Wales. The Depositary Shares represent a beneficial ownership interest in our Ordinary Shares.
The rights of holders of Depositary Shares are governed by English law, our constitutional documents, and the deposit agreement pursuant
to which the Depositary Shares are issued. The rights and terms of the Depositary Shares are designed to replicate, to the extent reasonably
practicable, the rights attendant to the Ordinary Shares, for which there is currently no active trading market in the United States.
However, because of aspects of United Kingdom law, our constitutional documents and the terms of the deposit agreement, the rights of
holders of Depositary Shares will not be identical to and, in some respects, may be less favorable than, the rights of holders of Ordinary
Shares.

You may not have the same voting rights as the holders of our Ordinary Shares and may not receive voting materials in time to be able to exercise your